Stay updated on AKST4290 with Aflibercept in nAMD Clinical Trial
Sign up to get notified when there's something new on the AKST4290 with Aflibercept in nAMD Clinical Trial page.

Latest updates to the AKST4290 with Aflibercept in nAMD Clinical Trial page
- Check6 days agoChange DetectedThe site footer now displays revision v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedA new revision entry Revision: v3.7.0 was added to the study record history, and the previous Revision: v3.6.6 was removed.SummaryDifference0.1%

- Check48 days agoChange DetectedThe study history now includes a new revision entry (v3.6.6), updating the version history to reflect the latest platform release.SummaryDifference0.1%

- Check69 days agoChange DetectedThe study record history shows a new revision entry (v3.6.5) and removes the previous revision (v3.6.4) from the visible list, reflecting an updated versioning state.SummaryDifference0.1%

- Check83 days agoChange DetectedThe study record history now shows a new latest revision (v3.6.4) replacing the previous v3.6.3 in the version list.SummaryDifference0.1%

- Check105 days agoChange DetectedA new version tag (v3.6.3) appears in the study history, replacing the previous v3.6.2. This signifies an administrative update or quality-control revision to the record rather than changes to study data.SummaryDifference0.1%

Stay in the know with updates to AKST4290 with Aflibercept in nAMD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AKST4290 with Aflibercept in nAMD Clinical Trial page.